Natural and cellular immune responses in Flinders Sensitive and Resistant Line rats

Neuropsychopharmacology

Volumn 15, Issue 3, 1996, Pages 314-322

  Friedman, Elliot M ^a,c   Irwin, Michael R ^a   Overstreet, David H ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Depression; Flinders Sensitive Line; Interleukin 2; Lymphocyte proliferation; Natural killer

Indexed keywords

CYTOKINE;

ANIMAL MODEL; ARTICLE; DEPRESSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNITY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030249238     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0893-133X(95)00235-6     Document Type: Article

References (56)

1. Ayensu WK, Pucilowski O, Mason GA, Overstreet DH, Rezvani AH, Janowsky DS (1995): Effects of chronic mild stress on serum complement activity, saccharin preference and corticosterone levels in Flinders lines of rats. Physiol Behav 57:165-169
2. Besedovsky H, Sorkin E, Keller M, Muller J (1975): Changes in blood hormone levels during the immune response. Proc Soc Exp Biol Med 150:466-470
3. Casale GP, Bavari S, Gold RE, Vitzthum EF (1992): Inhibition of interleukin-2-stimulated enhancement of human natural killer (NK) cell activity by carbaryl, an anticholinesterase insecticide. Toxicol Let 63:299-311
4. Chambers WH, Vujanovic NL, DeLeo AB, Olszowy MW, Herberman RB, Hiserodt JC (1989): Monoclonal antibody to a triggering structure expressed on rat killer cells and adherent lymphokine-activated killer cells. J Exp Med 169:1373-1389
5. Coe CL (1993): Psychosocial factors and immunity in nonhuman primates: A review. Psychosom Med 55:298-308
6. Darko DF, Gillin JC, Risch SC, Bulloch K, Golshan S, Tasevska Z, Hamburger RN (1989): Immune cells and the hypothalamic-pituitary axis in major depression. Psychiatry Res 25:173-179
7. Darko DF, Irwin MR, Risch SC, Gillin JC (1992): Plasma beta-endorphin and natural killer cell activity in patients with major depression. Psychiatry Res 43:111-119
8. Demissie S, Rogers CF, Hiramoto NS, Ghanta VK, Hiramoto RN (1995): Arecoline a muscarinic cholinergic agonist conditions central pathways that modulate natural killer cell activity. J Neuroimmunol 59:57-63
9. Djuric VJ, Overstreet DH, Bienenstock J, Perdue MH (1995): Immediate hypersensitivity in the Flinders rat: Further evidence for a possible link between susceptibility to allergies and depression. Brain Behav Immun 9:196-206
10. Evans DL, Folds JD, Petitto JM, Golden RN, Pedersen CA, Corrigan M, Gilmore JH, Silva SG, Quade D, Ozer H (1992): Circulating natural killer cell phenotypes in men and women with major depression. Relation to cytotoxic activity and severity of depression. Arch Gen Psychiatry 49:388-395
11. Glaser R, Kennedy S, Lafuse WP, Bonneau RH, Speicher C, Hillhouse J, Kiecolt-Glaser JK (1990): Psychological stress-induced modulation of interelukin-2 receptor gene expression and interleukin-2 production in peripheral blood leukocytes. Arch Gen Psychiatry 47:707-712
12. Herbert TB, Cohen S (1993a): Depression and immunity: A meta-analytic review. Psychol Bull 113:472-486
13. Herbert TB, Cohen S (1993b): Stress and immunity in humans: A meta-analytic review. Psychosom Med 55:364-379
14. Irwin MR (1995): Psychoneuroimmunology of depression. In Bloom FE, Kupfer DJ (eds), Psychopharmacology: The Fourth Generation of Progress. New York, Raven, pp 983-998
15. Irwin MR, Gillin JC (1987): Impaired natural killer cell activity among depressed patients. Psychiatry Res 20:181-182
16. Irwin MR, Smith TL, Gillin JC (1987): Reduced natural killer cytotoxicity in depressed patients. Life Sci 41:2127-2133
17. Irwin MR, Hauger RL, Jones L, Provencio M, Britton KT (1990): Sympathetic nervous system mediates central corticotropin-releasing factor induced suppression of natural killer cytotoxicity. J Pharmacol Exp Ther 255(1): 101-107
18. Irwin MR, Brown M, Patterson T, Hauger R, Mascovich A, Grant I (1991): Neuropeptide Y and natural killer cell activity: Findings in depression and Alzheimer caregiver stress. FASEB J 5:3100-3107
19. Irwin M, Lacher U, Caldwell C (1992): Depression and reduced natural killer cell cytotoxicity: A longitudinal study of depressed patients and control subjects. Psychol Med 22:1045-1050
20. Irwin MR, Friedman EM (in press): Developmental aspects of psychoneuroimmunology. In Lewis M (ed), Child and Adolescent Psychiatry: A Textbook, ed. 2. Baltimore, William & Wilkins
21. Kang D, Davidson RJ, Coe CL, Wheeler RE, Tomarken AJ (1991): Frontal brain asymmetry and immune function. Behav Neurosci 105:860-869
22. Keller SE, Weiss JM, Schleifer SJ, Miller NE, Stein M (1983): Stress-induced suppression of immunity in adrenalectomized rats. Science 221:1301-1304
23. Kronfol Z, House JD (1985): Depression, hypothalamic-pituitary adrenocortical activity and lymphocyte function. Psychopharmacol Bull 21:476-478
24. Kronfol Z, Silva J, Greden J, Dembinski S, Gardner R, Carroll B (1983): Impaired lymphocyte function in depressive illness. Life Sci 33:241-247
25. Laudenslager ML, Ryan SM, Drugan RC, Hyson RL, Maier SF (1483): Coping and immunosuppression: Inescapable but not escapable shock suppresses lymphocyte proliferation. Science 221:568-570
26. Laudenslager ML, Fleshner M, Hofstadter P, Held PE, Simons L, Maier SF (1988): Suppression of specific antibody production by inescapable shock: Stability under varying conditions. Brain Behav Immun 2:92-101
27. Levy EM, Borrelli DJ, Mirin SM, Salt P, Knapp PH, Peirce C, Fox BH, Black PH (1991): Biological measures and cellular immunological function in depressed psychiatric inpatients. Psychiatry Res 36:157-167
28. Madden KS, Ackerman KD, Livnat S, Felten S, Felten DL (1993): Neonatal sympathetic denervation alter the development of natural killer (NK) cell activity in F344 rats. Brain Behav Immun 7:344-351
29. Maes M, Bosmans E, Suy E, Vandervorst C, deJonckheere C, Raus J (1991): Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1β and soluble interleukin-2 receptor production. Acta Psychiatr Scand 84:379-386
30. Maes M, Lambrechts J, Suy E, Vandervorst C, Bosmans E (1994a): Absolute number and percentage of circulating natural killer, non-MHC-restricted T cytotoxic, and phagocytic cells in unipolar depression. Neuropsychobiol 29:157-163
31. Maes M, Meltzer HY, Stevens W, Calabrese J, Cosyns P (1994b): Natural killer cell activity in major depression: Relation to circulating natural killer cells, cellular indices of the immune response, and depressive phenomenology. Prog Neuropsychopharmacol Biol Psychiatry 18:717-730
32. Maier SF (1984): Learned helplessness and animal models of depression. Prog Neuropsychopharmacol Biol Psychiatry 8:435-446
33. Maier SF, Laudenslager ML (1988): Inescapable shock, shock controllability, and mitogen stimulated lymphocyte proliferation. Brain Behav Immun 2:87-91
34. Munck A, Guyre PM, Holbrook NJ (1984): Physiological functions of glucocorticoids in stress and their relation to pharmacologic actions. Endocr Rec 5:25-44
35. Nair MPN, Schwartz SA, Wu K, Kronfol Z (1993): Effect of neuropeptide Y on natural killer activity of normal human lymphocytes. Brain Behav Immun 7:70-78
36. Nerozzi D, Santoni A, Bersani G, Magnani A, Bressan A, Pasini A, Antonozzi I, Frajese G (1989): Reduced natural killer cell activity in major depression: Neuroendocrine implications. Psychoneuroendocrinology 14:295-301
37. Nicolls MR, Aversa GG, Pearce NW, Spinelli A, Berger MF, Gurley KE, Hall BM (1993): Induction of long-term specific tolerance to allografts in rats by therapy with an anti-CD3-like monoclonal antibody. Transplantation 55: 459-468
38. Overstreet DH (1986): Selective breeding for increased cholinergic function: Development of a new animal model of depression. Biol Psychiatry 21:49-58
39. Overstreet DH (1992): Genetic animal models of endogenous depression. In Driscoll P (ed), Genetically-Defined Animal Models of Neurobehavioral Dysfunction. Boston, Birkhauser, pp 81-114
40. Overstreet DH (1993): The Flinders Sensitive Line rats: A genetic animal model of depression. Neurosci Biobehav Rev 17:51-68
41. Overstreet DH, Russell RW, Helps SC, Messenger M (1979): Selective breeding for sensitivity to the anticholinesterase, DFP. Psychopharmacology 65:15-20
42. Overstreet DH, Booth R, Dana R, Risch SC, Janowsky DS (1986): Enhanced elevation of corticoserone following arecoline administration to rats selectively bred for increased cholinergic function. Psychopharmacology 88: 129-130
43. Petitto JM, Lysle DT, Gariepy J, Clubb PH, Cairns RB, Lewis MH (1993): Genetic differences in social behavior: Relation to natural killer cell function and susceptibility to tumor development. Neuropsychopharmacol 8:35-43
44. Petitto JM, Lysle DT, Gariepy J, Lewis MH (19940: Association of genetic differences in social behavior and cellular immune responsiveness: Effects of social experience. Brain Behav Immun 8:111-122
45. Pross HF, Maroun JA (1984): The standardization of NK cell assays for use in studies of biological response modifiers. J Immunol Methods 68:235-249
46. Rinner I, Felsner P, Falus A, Skreiner E, Kukulansky T, Globerson A, Hirokawa K, Schauenstein K (1995): Cholinergic signals to and from the immune system. Immunol Lett 44:217-220
47. Ritz J (1989): The role of natural killer cells in immune surveillance. N Engl J Med 320:1748-1749
48. Rosenstreich DL, Mizel SB (1978): The participation of macrophages and macrophage cell lines in the activation of T lymphocytes by mitogens. Immunol Rev 40:102-135
49. Sacerdote P, Manfredi B, Bianchi M, Panerai AE (1994): Intermittent but not continuous inescapable footshock stress affects immune responses and immunocyte beta-endorphin concentrations in the rat. Brain Behav Immun 8:251-260
50. Salamon FT, Fayen JD, Leonard ML, Finegan CK, Rich EA (1992): Accessory function of human mononuclear phagocytes for lymphocyte responses to the superantigen Staphylococcal Enterotoxin B. Cell Immunol 141: 466-484
51. Schleifer SJ, Keller SE, Meyerson AT, Raskin MJ, Davis KL, Stein M (1984): Lymphocyte function in major depressive disorder. Arch Gen Psychiatry 41:484-486
52. Schleifer SJ, Keller SE, Bond RN, Cohen J, Stein M (1989): Major depressive disorder and immunity: Role of age, sex, severity, and hospitalization. Arch Gen Psychiatry 46:81-87
53. Trinchieri G (1989): Biology of natural killer cells. Adv Immunol 47:187-376
54. Urich A, Muller CH, Aschauer H, Resch F, Zielinski CC (1988): Lytic effector cell function in schizophrenia and depression. J Neuroimmunol 18:291-301
55. Whiteside TL, Herberman RB (1989): The role of natural killer cells in human disease. Clin Immunol Immunopathol 53:1-23
56. Willner P (1991): Animal models as simulations of depression. Trends Neurosci 12:131-136